Search

NeoGenomics Inc

Abierto

SectorSanidad

19.17 0.37

Resumen

Variación precio

24h

Actual

Mínimo

18.71

Máximo

19.32

Métricas clave

By Trading Economics

Ingresos

19M

2.2M

Ventas

15M

202M

BPA

-0.01

Margen de beneficios

1.11

Empleados

2,500

EBITDA

19M

19M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-2.95% downside

Dividendos

By Acuity

Próximas Ganancias

27 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

654M

2.4B

Apertura anterior

18.8

Cierre anterior

19.17

Noticias sobre sentimiento de mercado

By Acuity

76%

24%

304 / 339 Clasificación en Healthcare

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 sept 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 sept 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 sept 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 sept 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 sept 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 sept 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 sept 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 sept 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 sept 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 ago 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 ago 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 ago 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

26 ago 2026, 23:01 UTC

News

Neogenomics Inc secures expanded Medicare coverage for RaDaR ST assay, enhancing immunotherapy monitoring. Shares are trading higher in after-market hours.

25 ago 2026, 23:02 UTC

Neogenomics Inc is trading higher in after-market hours, remaining near the upper end of its one-month range and above its 20-day moving average.

24 ago 2026, 23:06 UTC

Neogenomics Inc shares are lower in after-market trading, with no specific news identified. Broader market concerns include the U.S.-Iran conflict and oil supply disruptions.

21 ago 2026, 20:06 UTC

Neogenomics shares are higher, benefiting from a strong trend in the Health Care Services sub-sector, despite no specific company news identified.

20 ago 2026, 21:26 UTC

Neogenomics Inc's shares are higher in after-market trading, maintaining a stable performance since Thursday's close amid no specific news or developments.

19 ago 2026, 19:26 UTC

Neogenomics Inc shares are higher today amid strong buying interest. The stock is approaching the upper end of its one-month trading range.

18 ago 2026, 19:36 UTC

Neogenomics Inc shares are lower today amid broader economic concerns, including rising treasury yields and inflation pressures. The stock reached a session low earlier.

17 ago 2026, 22:01 UTC

Neogenomics Inc is rising in after-market trading, reflecting a strong performance following Monday's close amid a generally positive trading environment and heightened volatility.

14 ago 2026, 23:01 UTC

Neogenomics Inc shares are lower in after-market hours, following a decline influenced by mixed market sentiment and a drop in U.S. retail sales.

13 ago 2026, 22:02 UTC

Neogenomics Inc. shares fell in after-market trading, declining since Thursday's close, despite broader market averages closing higher earlier in the day.

12 ago 2026, 23:51 UTC

Neogenomics Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close, despite no specific news identified.

11 ago 2026, 19:26 UTC

Neogenomics Inc. shares are lower today, with no specific news identified. Investors await U.S. inflation reports that may impact market sentiment.

10 ago 2026, 22:26 UTC

Neogenomics Inc shares are higher in after-market trading, remaining above their 20-day moving average despite no specific news. Rising Treasury yields may influence sentiment.

7 ago 2026, 20:03 UTC

Neogenomics Inc shares are higher during Friday's session, reflecting strong market performance. The stock has advanced since Thursday's close, despite a recent pullback.

6 ago 2026, 21:51 UTC

Neogenomics Inc shares are higher in after-market trading, reaching a notable high and remaining above their 20-day moving average. No specific news was identified.

5 ago 2026, 19:36 UTC

Neogenomics Inc shares are lower today, reversing earlier gains despite no specific news. Broader market sentiment reflects easing inflation concerns amid declining crude oil prices.

4 ago 2026, 19:33 UTC

Social Media

Neogenomics Inc. shares are higher amid social media discussions on long-term investment strategies, despite negative narratives about the company's performance.

3 ago 2026, 20:03 UTC

Neogenomics Inc shares are higher today, reflecting overall market momentum. The S&P 500 and Nasdaq 100 also posted gains during the session.

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

-2.95% descenso

Estimación a 12 Meses

Media 18.333 USD  -2.95%

Máximo 21 USD

Mínimo 16 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

5

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

304 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat